These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6331910)

  • 1. Molecular characteristics and biological properties (genetic markers) of candidate strains for preparation of live influenza virus vaccines.
    Ghendon YZ
    Bull World Health Organ; 1984; 62(3):493-9. PubMed ID: 6331910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory and clinical evaluation of new live influenza virus vaccines. Need for minimum requirements.
    Huygelen C
    Dev Biol Stand; 1977 Jun 1-3; 39():155-60. PubMed ID: 342307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain.
    Medvedeva TE; Gordon MA; Ghendon YZ; Klimov AI; Alexandrova GI
    Acta Virol; 1983 Jul; 27(4):311-7. PubMed ID: 6195900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 'in vitro' marker of attenuation for live influenza virus vaccine candidates.
    Mostow SR; Flatauer S; Martinko J
    Dev Biol Stand; 1975; 28():354-62. PubMed ID: 1126579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Location of ts defects in the genome of cold-adapted recombinant influenza A virus vaccine strains.
    Medvedeva TE; Lisovskaya KV; Polezhaev FI; Garmashova LM; Alexandrova GI; Ghendon YZ
    Acta Virol; 1984 May; 28(3):204-11. PubMed ID: 6147996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on influenza-virus virulence in recombinants between epidemic and vaccine strains.
    Zazimko LA; Vakin VS; Sklyanskaya EI; Zhdanov VM
    Acta Virol; 1987 Sep; 31(5):387-96. PubMed ID: 2891277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro markers for measuring residual virulence for men of live attenuated influenza viruses.
    Boudreault A; Diaz-Rodriguez P; Lecomte J
    Dev Biol Stand; 1977 Jun 1-3; 39():33-40. PubMed ID: 604117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfering activity of virulent and attenuated influenza virus strains.
    Dekhtyareva NI; Medvedeva TE; Aleksandrova GI
    Acta Virol; 1976 Jun; 20(3):189-95. PubMed ID: 9798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory and clinical characteristics of attenuated strains of influenza virus.
    Maassab HF; Francis T; Davenport FM; Hennessy AV; Minuse E; Anderson G
    Bull World Health Organ; 1969; 41(3):589-94. PubMed ID: 5309481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic techniques for the production of influenza vaccines (author's transl)].
    Teti G
    Ann Sclavo; 1980; 22(1):34-9. PubMed ID: 7018413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of live influenza vaccines.
    Smorodincev AA
    Bull World Health Organ; 1969; 41(3):585-8. PubMed ID: 5309480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiments in the preparation of live influenza B vaccines.
    Beare AS; Sherwood JE; Callow KA; Craig JW
    Dev Biol Stand; 1977 Jun 1-3; 39():85-9. PubMed ID: 604138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of individual genes in expression of phenotypic properties of the cold-adapted strain A/Leningrad/134/47/57 (H2N2)-a donor of attenuation of live influenza vaccine].
    Medvedeva TE; Kudriavtseva VK; Nevedomskaia GN; Zhikhareva IV; Gushchina MI; Zolotarev FN; Vodeĭko GM; Lisovskaia KV; Iotov VV; Khaĭder MI
    Genetika; 1993 Apr; 29(4):681-9. PubMed ID: 8354475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics of influenza viruses].
    Döhner L
    Arch Exp Veterinarmed; 1978; 32(3):399-406. PubMed ID: 697527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future influenza vaccines and the use of genetic recombinants.
    Kilbourne ED
    Bull World Health Organ; 1969; 41(3):643-5. PubMed ID: 5309489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental basis of enhancing the immunogenicity of influenza B virus by genetic recombination.
    Medvedeva TE; Gordon MA; Aleksandrova GI; Smorodintsev AA
    Acta Virol; 1980 Dec; 24(6):385-90. PubMed ID: 6111198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-yield reassortant influenza vaccine production virus has a mutation at an HLA-A 2.1-restricted CD8+ CTL epitope on the NS1 protein.
    Terajima M; Jameson J; Norman JE; Cruz J; Ennis FA
    Virology; 1999 Jun; 259(1):135-40. PubMed ID: 10364497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditions for production of thermosensitive attenuated influenza virus recombinants.
    Polezhaev FI; Garmashova LM; Polyakov YM; Golubev DB; Aleksandrova GI
    Acta Virol; 1978 Jul; 22(4):263-9. PubMed ID: 29464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.